Search Results
Jan 19, 2026, 09:00 ET VEVOR Redefines the Impact Socket Master Set: The One-Stop Solution for High-Torque Precision, Now Ready for Your Spring Projects
VEVOR Impact Socket Master Sets are engineered to withstand repeated high-torque impact without deforming or losing performance. Forged from durable CR-V alloy steel, each socket is designed to hold up where ordinary tools often fall short.Precision matters just as much as strength. A 6-point
More news about: VEVOR
Jan 16, 2026, 13:54 ET IBV Auto: CR-V, Clio e Jetta lideram altas, enquanto Peugeot 206 e VW Golf registram as maiores quedas entre os usados em 2025
usados no país, Honda, Toyota e Renault foram as marcas que registraram valorização superior a 7% no acumulado do ano. Na Honda, o CR-V apresentou desempenho expressivo, com alta de 26,9% em 2025. Modelos de grande volume também contribuíram para o resultado da marca, como o Civic,
More news about: Banco BV
Jan 16, 2026, 09:03 ET Top Crunch Fitness Franchise CR Fitness Holdings Surpasses 1 Million Member Milestone
designed to support individual goals.About CR Fitness Holdings, LLCCR Fitness Holdings, LLC is the leading franchisee of Crunch Fitness, and led by a management team with over 150 years of combined experience in the fitness industry. CR Fitness is on track to operate 110 locations nationwide
More news about: CR Fitness Holdings, LLC.
Jan 15, 2026, 20:00 ET Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
efficacious dose range of 1.8-2.4 mg/kg, the ORR was 28.6% (6/21). In addition, one patient in each of the three dose groups achieved a complete response (CR). These results demonstrated the potent anti-tumor activity of ATG-022 across all levels of CLDN18.2 expression. Promising frontline combination
More news about: Antengene Corporation Limited
Jan 15, 2026, 14:07 ET Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
pivotal CK-301-101 clinical trial. This study showed improvements in objective response rates (including more patients who achieved a complete response [CR]) and duration of response. The safety data did not change from the original UNLOXCYT label.Many patients in the pivotal trial experienced durable
More news about: Sun Pharma
Jan 14, 2026, 16:30 ET TECVAYLI® monotherapy demonstrates superior progression-free and overall survival versus standard of care as early as first relapse in patients with multiple myeloma predominantly refractory to anti-CD38 therapy and lenalidomide
TECVAYLI® for a reduced dosing frequency of 1.5 mg/kg every two weeks in patients with RRMM who achieved and maintained a complete response (CR) or better for a minimum of six months. Since FDA approval, more than 20,800 patients have been treated worldwide with TECVAYLI®.The
More news about: Johnson & Johnson
Jan 13, 2026, 08:49 ET Tata Elxsi delivers healthy growth in Q3 FY'26
the company's performance in the third quarter of FY26, said:"For the third quarter of FY'26, Tata Elxsi reported operating revenues of 953.5 Cr, a growth of 3.9% QoQ.Growth was led by our transportation business, with accelerated ramp-ups in SDV led OEM deals won earlier in the year, and
More news about: Tata Elxsi
Jan 13, 2026, 03:26 ET Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
overall survival (OS) of 10.3 months (95% CI: 6.1, NA).Notably, one patient in the 2.5×10⁸ CAR-T cell dose cohort achieved a complete response (CR) and has remained tumor-free for 60 weeks, demonstrating antitumor activity following IMC002 treatment in a heavily pretreated setting.Further
More news about: Immunofoco Biotechnology
Jan 12, 2026, 13:48 ET Boehringer Ingelheim and CommonSpirit Health Collaborate to Improve Cardio-Kidney-Metabolic Screening and Diagnosis in Vulnerable Populations
https://www.nejm.org/doi/10.1056/NEJMsa022615?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov
More news about: Boehringer Ingelheim Pharmaceuticals, Inc.; CommonSpirit Health
Jan 12, 2026, 06:45 ET Canada Nickel Announces 46% Increase in Measured & Indicated Resource at Reid Nickel Sulphide Project
Fe (%) Cr (%) S (%)
More news about: Canada Nickel Company Inc.
Jan 08, 2026, 12:30 ET EaseUS Tackles Fragmented SD Card Files with SmartSector Rebuild (SSR) in Data Recovery Wizard 20.1.0, Boosting Recovery by Up to 30%
imagesVideos that only play the first few seconds or refuse to open4K and 6K footage appears corrupted after camera formattingRAW files (CR2, NEF, ARW, DNG) are missing critical data blocksIn many cases, traditional recovery tools fail because the metadata linking these fragmented
More news about: EaseUS
Jan 08, 2026, 04:00 ET Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD
sooner.CTx001 is a novel adeno-associated virus (AAV)-based gene therapy designed to deliver a truncated version of Complement Receptor 1 (mini-CR1), with the potential for long-term potent modulation of the classical and alternative pathways of the complement cascade. GA is an advanced form of
More news about: Complement Therapeutics
Jan 07, 2026, 09:00 ET Global Cybersecurity and AI Leaders from Defense, IT, OT, SLED, and Behavioral Science to Headline the 2026 SimSpace Summit
Republic of Slovenia: Federating Cyber Ranges for Cross-Country Collaboration, Presented by Aleš Čretnik, Cybersecurity Advisor / CR Chief, Defence Ministry of Republic of SloveniaCyber Florida: Accelerating Cybersecurity Adoption and Transformation, Presented
More news about: SimSpace Corporation
Jan 06, 2026, 14:31 ET North Castle Partners Announces Promotions
investments and currently manages the Firm's investments in Encore Vet Group, EVG Specialty Network, and BlueRoot Health, and sits on the Board of Directors of CR Fitness and Sparx Hockey. John has also been actively involved in the execution and due diligence of new investment opportunities across a variety of
More news about: North Castle Partners, L.L.C.
Jan 06, 2026, 08:48 ET A JBNU-KIMS Collaborative Study on a Cost-Effective Alloy Matches Superalloys for Power Plants and Energy Infrastructure
traditional austenitic stainless steels (ASSs) fail in these conditions. Ni- and Fe-based heat-resistant alloys possess protective chromia (Cr2O3) and/or α-alumina (Al2O3) oxide scales, they also suffer from various limitations. Therefore, there is an urgent need
More news about: Jeonbuk National University
Jan 05, 2026, 07:00 ET 科倫博泰ITGB6 ADC SKB105臨床試驗申請獲NMPA批准
2025年12月，科倫博泰與Crescent Biopharma, Inc. (「Crescent」)就SKB105/CR-003與SKB118 (PD-1 x VEGF雙抗，亦稱CR-001)達成戰略合作，其中科倫博泰授予Crescent在美國、歐洲及所有其他大中華地區(包括中國內地、香港、澳門及台灣)以外市場研究、開發、生產和商業化SKB105/CR-003的獨家權利，Crescent則授予科倫博泰在大中華地區研究、開發、生產和商業化SKB118/CR-001的獨家權利。SKB118/CR-001的IND申請已獲美國食品藥品監督管理局(FDA)批准, 即將啟動治療晚期實體瘤的I/II期全球臨床試驗。科倫博泰計
More news about: 科倫博泰
Jan 05, 2026, 07:00 ET Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
entered into a strategic collaboration for SKB105/CR-003 and SKB118 (a PD-1 x VEGF bispecific antibody, also known as CR-001). Under the collaboration, Kelun-Biotech granted Crescent exclusive rights to research, develop, manufacture and commercialize SKB105/CR-003 in the United States, Europe and all other
More news about: Kelun-Biotech
Jan 04, 2026, 21:00 ET C&R Research, "K-Clinical Hub", Mempererat Kemitraan di Indonesia
content:https://www.prnewswire.com/id/rilis-berita/cr-research-k-clinical-hub-mempererat-kemitraan-di-indonesia-302649521.htmlSOURCE
More news about: C&R Research Inc.
Dec 31, 2025, 09:09 ET Top Crunch Fitness Franchisee Nears 100 locations with opening of State-of-the-Art Facility in Dr. Phillips, FL
in our Florida growth," said Tony Scrimale, CEO of CR Fitness Holdings. "This 3.0 location elevates the member experience with upgraded amenities, cutting-edge equipment, and an energetic environment designed to bring the community together."CR Fitness Holdings is on track to operate 100 locations
More news about: CR Fitness Holdings, LLC.
Dec 30, 2025, 18:13 ET Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness
P-mediated pathways.ReferencesPolymeropoulos VM, Kiely L, Bushman ML, Sutherland EB, Goldberg AR, Pham AX, Miller CR, Mourad R, Davis TR, Pham NV, Morgan DB, Giles AK, Xiao C, Polymeropoulos CM, Birznieks G, Polymeropoulos MH. Motion Syros: tradipitant effective in the
More news about: Vanda Pharmaceuticals Inc.
Dec 28, 2025, 19:10 ET CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596
median follow-up of 4.14 months. Six patients achieved a partial response (PR) or better: 3 achieved complete response/stringent complete response (CR/sCR) (all received full-dose lymphodepletion), 1 achieved very good partial response (VGPR), and 2 achieved PR. Four patients experienced Grade 1 cytokine
More news about: CARsgen Therapeutics
Dec 26, 2025, 09:03 ET Top Crunch Fitness Franchisee Helps Members Reclaim Their Fitness Goals During "Get It Back Week"
Fitness App.CR Fitness Holdings, LLC, led by industry veterans Vince Julien, Geoff Dyer, Tony Scrimale, and Jeff Dotson, currently operates 88 Crunch Fitness locations across Florida, Texas, Georgia, North Carolina, and Tennessee - with plans to expand into Arizona.About CR Fitness Holdings,
More news about: CR Fitness Holdings, LLC.
Dec 23, 2025, 06:43 ET PDS Strengthens Manufacturing Leadership to Drive Growth and Operational Excellence
solution, engaging dedicated talent and infrastructure as an extended arm of retailers and brands. The Company reported consolidated revenues of ₹12,578cr in FY25.PDS is listed on leading stock exchanges in India, BSE Ltd. (Scrip Code: 538730) and the National Stock Exchange of India Ltd (Scrip
More news about: PDS
Dec 23, 2025, 04:58 ET Conversational English Improvement Startup EnglishYaari Secures ₹1 Crore Funding at ₹10 Crore Valuation, Bihar Startup Founders Plan Scaling to 50 cr ARR by 2027
dormitory, EnglishYaari has grown to serve 100,000+ registered users across the nation and even overseas, and hit ₹5 cr ARR in just under 3 years. The founders are aiming to scale growth to ₹50 cr ARR (annual revenue rate) by 2027 by expanding operations, targeting new geographies and introducing AI based self-learning
More news about: EnglishYaari
Dec 19, 2025, 07:55 ET Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
relapsed/refractory diffuse large B-cell lymphoma. The combination demonstrated strong efficacy in both relapsed (100% ORR, 91.7% CR) and primary refractory populations (80% ORR, 64% CR) while maintaining a manageable safety profile with cytokine release syndrome occurring in 36.7% of patients across dose levels."We're
More news about: Equity Insider